Equities Analysts Offer Predictions for PAHC Q4 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research increased their Q4 2025 EPS estimates for Phibro Animal Health in a research report issued on Wednesday, February 19th. Zacks Research analyst R. Department now expects that the company will earn $0.50 per share for the quarter, up from their previous estimate of $0.43. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.53 EPS, Q4 2026 earnings at $0.59 EPS, FY2026 earnings at $1.91 EPS, Q2 2027 earnings at $0.55 EPS and FY2027 earnings at $2.17 EPS.

Several other research firms have also commented on PAHC. Barclays increased their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Finally, Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Performance

PAHC stock opened at $22.50 on Friday. The firm has a market cap of $911.25 million, a price-to-earnings ratio of 46.88, a PEG ratio of 0.45 and a beta of 0.52. The firm has a 50-day simple moving average of $22.21 and a two-hundred day simple moving average of $22.14. Phibro Animal Health has a one year low of $11.98 and a one year high of $26.55. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC increased its holdings in shares of Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after acquiring an additional 27,201 shares in the last quarter. Barclays PLC increased its holdings in Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares during the period. Algert Global LLC increased its holdings in Phibro Animal Health by 521.1% in the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after buying an additional 59,850 shares during the period. FMR LLC increased its holdings in Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after buying an additional 7,270 shares during the period. Finally, BNP Paribas Financial Markets increased its holdings in Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.13%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.